6-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-1-carboxylic acid, 97.0%, 5g

(4-METHYLTHIOPHEN-2-YL)METHANAMINE HYDROCHLORIDE, 95%, 25g

1,6-DIBROMOISOQUINOLINE, 95%, 250mg

Triphenylethoxysilane, 95%, 1g

1-(3-fluorophenyl)-3-(2-hydroxy-4-methylphenyl)propane-1,3-dione, 95.0%, 1g

(2S)-3-(1-bicyclo[1.1.1]pentanyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid, 97, 50mg

1-sec-butyl-1H-pyrazol-3-amine, 95.0%, 2g

(1,4-Oxazepan-2-yl)methanol hydrochloride, 95.0%, 1g

(S)-4-Methoxy-3-methyl-4-oxobutanoic acid, 97%, 100mg

4-Fluoro-3-iodoanisole, 97%, 5g

Triphenylphosphine dibromide, 95.0%, 25g

Microliter syringe GASTIGHT® series 1000, 5.0 ml, 1005 TLL, 1 piece

4-Isobutyldihydro-2H-pyran-2,6(3H)-dione, 95.0%, 100g